Quest diagnostics adds diabetic retinopathy screening through its patient service centers in collaboration with iris

New capability enables individuals identified as high-risk by participating health plans to access screening through a quest diagnostics site builds on quest's extended care services to improve care quality and outcomes in diabetes and other chronic diseases secaucus, n.j. , april 4, 2022 /prnewswire/ -- quest diagnostics (nyse: dgx), the world's leading provider of diagnostic information services, today announced a collaboration with iris (intelligent retinal imaging systems) to deliver diabetic retinal imaging services through designated quest diagnostics patient service centers across the united states to aid in screening patients for retinal assessment by a healthcare provider.
DGX Ratings Summary
DGX Quant Ranking